share_log

ACTO ACQUIRES 4TH DOWN SOLUTIONS, BRINGING TOGETHER TWO INDUSTRY LEADERS

ACTO ACQUIRES 4TH DOWN SOLUTIONS, BRINGING TOGETHER TWO INDUSTRY LEADERS

ACTO收購4TH DOWN SOLUTIONS,將兩個行業領導者合併在一起。
PR Newswire ·  06/11 20:00

Strategic Acquisition Adds to ACTO's Organic Customer Growth in Top 50 Pharma

戰略收購爲創業板前50大藥品客戶增長增添了ACTO的有機客戶

KISSIMMEE, Fla., June 11, 2024 /PRNewswire/ - Today at the Life Sciences Trainers & Educators Network (LTEN) Annual Conference, ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform purpose-built for the life science industry, announced its acquisition of 4th Down Solutions (4DS), a leading provider of innovative mobile technology and data-driven learning solutions for biopharmaceutical companies. Founded in 2010, 4DS disrupted the industry with their technology and approach by shifting commercial training from a once-and-done exercise to a continuous learning technique to impact field sales performance.

2024年6月11日,佛羅里達州基西米市/美通社/——今天在生命科學培訓師和教育者網絡(LTEN)年會上,ACTO宣佈收購4th Down Solutions(4DS),這是領先的爲生物製藥公司提供創新移動技術和數據驅動學習解決方案的供應商,爲擁有人工智能動力的專爲生命科學行業打造的智能化現場卓越表現(IFE)平台唯一提供商。4DS成立於2010年,通過將商業培訓從一勞永逸的鍛鍊變成具有持續學習技巧以影響現場銷售業績的方法,他們的技術和方法顛覆了這個行業。

"Our longstanding strategic collaboration with 4DS has been indispensable in helping Encompass Communications and Learning boost training engagement, provide insightful metrics, and empower clients, such as Teva Pharmaceuticals, to lead the industry and improve the lives of patients," said Jon Madden, Managing Partner at Encompass.

“我們長期與4DS的戰略合作對於幫助Encompass Communications and Learning促進培訓參與,提供有見地的指標以及賦予Teva Pharmaceuticals等客戶引領行業並改善患者生活的能力非常重要,”Encompass的董事總經理Jon Madden表示。

"We're eager to see how our partnership with Encompass, enhanced by ACTO's platform and expanded capabilities, enables Teva's sales team to deliver even greater impact," said Jon Miller, SVP, Innovative Medicines Sales & Field Operations at Teva Pharmaceuticals.

“我們很想看到ACTO平台和擴展能力加強了與Encompass的合作,使泰伯銷售團隊所產生的影響更爲強烈,”Teva Pharmaceuticals創新藥物銷售與現場運營高級副總裁Jon Miller表示。

"4DS was a pioneer in the evolution of commercial learning in the life sciences industry," said Parth Khanna, CEO of ACTO. "4DS propelled the industry to change the way they thought about field force training by making continuous, personalized learning based on data insights the new norm. With the path forged by 4DS, and ACTO's focus on expanding the way pharma reps are supported in the field through Intelligent Field Excellence, bringing these two companies together was very natural."

“4DS是生命科學行業商業學習進化的先驅者。”ACTO的首席執行官Parth Khanna說。“通過通過數據洞見驅動的持續個性化學習方法,4DS推動了該行業轉變了他們對現場人員培訓的想法。通過4DS鋪平的道路和ACTO專注於通過智能化現場卓越擴展製藥代表在現場受到支持的方式,將這兩家公司合併在一起非常自然。”

"We are delighted to join forces with ACTO as the benefits offered to both our customers and employees as a broader intelligent field excellence solution is unparalleled in the industry," said Brett Howell, CEO of 4th Down Solutions. "ACTO is leading the way in field force effectiveness in life sciences through innovation in data insight and AI, and we are excited to bring this to our customers."

“我們很高興與ACTO合作,因爲這將帶給我們的客戶和員工的好處是行業中無與倫比的智能現場卓越解決方案。”4th Down Solutions的首席執行官Brett Howell說。“ACTO正在通過數據洞見和人工智能掌握生命科學領域現場作用效能的領先者,我們很高興將這一點帶給我們的客戶們。”

For more information, visit .

要獲取更多信息,請訪問.

About ACTO
ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into "Masters of the Message" who engage HCPs and their support teams with authority and impact. With ACTO, biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness.

關於ACTO
ACTO是一個專爲生命科學打造的人工智能動力的智能化現場卓越(IFE)平台,幫助銷售,市場和醫療團隊通過將現場專業人員變成與HCPs和他們的支持團隊權威、有影響力的“信息大師”來提高客戶參與度和品牌表現。通過ACTO, 生物製藥公司可以確保現場專業人員始終胸有成竹,信心十足,並有說服力地向HCPs傳遞正確的信息,同時爲高層領導和一線經理提供他們需要的洞察力,以推動不斷提高現場作用效能。

2024 ACTO Technologies, Inc. | Only Intelligent Field Excellence (IFE) platform purpose-built for life sciences. All rights reserved. All product names and services are property of their respective owners.

2024 ACTO Technologies,Inc.|僅爲生命科學行業打造的智能化現場卓越(IFE)平台。保留所有權利。所有產品名稱和服務是其各自所有者的財產。

SOURCE ACTO Technologies, Inc.

ACTO Technologies,Inc.的資源

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論